Morgan Stanley (NYSE:MS) traded at $89.67 at close of the session on Tuesday, 11/22/22, made an upward move of 0.66% on its previous day’s price.
Looking at the stock we see that its previous close was $89.08 and the beta (5Y monthly) reads 1.33 with the day’s price range being $89.30 – $90.19. The company has a trailing 12-month PE ratio of 13.02. In terms of its 52-week price range, MS has a high of $109.73 and a low of $72.05. The company’s stock has gained about 12.89% over that past 30 days.
Morgan Stanley has a market cap of $151.13 billion and is expected to release its quarterly earnings report on Jan 17, 2023 – Jan 23, 2023. With its Forward Dividend at 3.10 and a yield of 3.46%, the company’s investors could be anxious for the MS stock to gain ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $29.42, with the EPS growth for the year raised at $126.84 for 2022 and $147.22 for next year. These figures represent -22.50% and 16.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $255.78 billion, with a low of $242.89 billion and a high of $263.53 billion. The median projection represents growth adding up to -13.60% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $1.07T, or -12.20% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the MS stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 29 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 9 have rated the Morgan Stanley (MS) stock as a Hold, while 17 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 2 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the MS stock currently stands at 8.64, and the current price level is 4.61% off its SMA20 and 7.88% from its 50-day simple moving average. The RSI (14) is pointing at 63.05 while the volatility over the past week is 1.54% and jumps to 2.19% over the past one month. The beta value is 1.31, while the average true range (ATR) is currently pointing at 2.22. The average price target for the stock over the next 12 months is $92.75, with the estimates having a low of $79.22 and a high of $105.00. These price ends are 11.65% and -17.1% off the current price level respectively, although investors could be excited at the prospect of a -2.6% if the MS share price touches on the median price of $92.00.
Let’s briefly compare Morgan Stanley (MS) stock to its peers. We find that current price change of 0.66% and -9.72% over the past 12 months for MS competes that of JPMorgan Chase & Co. (JPM), which has seen its stock price rise 1.50% in the last trading session and was -17.83% over the last one year. Another of its peers Wells Fargo & Company (WFC) has gained 0.58% previous session, and was -6.42% down over the past year, while The Charles Schwab Corporation (SCHW) was also up 1.58% in the last session, while its price remained in the red at -0.81% over the same period. Morgan Stanley has a P/E ratio of 13.02 compared to JPMorgan Chase & Co.’s 11.40 and Wells Fargo & Company’s 12.24. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at 1.36% and 1.18%, respectively, at close of the trading.
Coming back to Morgan Stanley (NYSE:MS), we note that the average 3-month trading volume was 7.84 million, while that of the preceding 10-day period stands at 5.98 million. Current shares outstanding are 1.67 billion.
The insiders hold 0.20% of the company’s shares while institutions hold 63.80%. The data shows that short shares as of Oct 13, 2022, stood at 17.97 million at a short ratio of 2.11. This represents a 1.06% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 23.06 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -8.65% down in year-to-date price movement.